#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

mnohočetný myelom

PHD 2022: In the treatment of multiple myeloma we have achieved significant progress, confirm real-world data

28. 3. 2022 Source: Hematologic Malignancies

The treatment options for multiple myeloma (MM) have significantly advanced over the past 10 years, and patient outcomes have improved. However, the most accurate guide is needed to select the right treatment modality for each particular patient among the many available options. During the Prague Hematology Days (PHD) 2022, this topic was addressed by Prof. MUDr. Roman Hájek, CSc., from the Hemato-Oncology Clinic of the Faculty of Medicine at the University of Ostrava and FN Ostrava.

Hodgkinův lymfom

Hodgkin Lymphoma in a Summary of News from Post-ASH 2021

Dr. Anna Suredová from the Clinical Hematology Department of the Catalonian Oncology Institute in…
28. 3. 2022 Source: Hematologic Malignancies
Streptococcus pneumoniae.

Current Insights into the Etiology of Community Pneumonia: Pneumococci Still Leading?

The etiology of community-acquired pneumonias has undergone certain changes since the beginning of…
25. 3. 2022 Source: Anti-Infectives
alergická rýma nosní sprej

Safe Long-term Treatment of Nasal Symptoms in Patients with Perennial Allergic Rhinitis

In persistent allergic rhinitis, achieving symptom control is often difficult despite…
24. 3. 2022 Source: Life Without Allergic Rhinitis
alergická rýma

Effect of Combination Therapy on Symptoms of Allergic Rhinitis

The aim of the study presented below by authors from the USA was to evaluate the efficacy, safety,…
24. 3. 2022 Source: Life Without Allergic Rhinitis
hypertenze a srdce ilustrace

Telmisartan –⁠ antihypertensive with cardioprotective effects

Sartans are potent inhibitors of the AT1 receptor for angiotensin II widely used in the therapy of…
24. 3. 2022 Source: Sartans in the Treatment of Hypertension
hypertenze a covid

Does the choice of therapy for primary hypertension in patients with COVID-19 affect the severity of the disease?

The effect of two commonly used antihypertensives was evaluated in a randomized clinical trial in…
24. 3. 2022 Source: Sartans in the Treatment of Hypertension
MUDr_Pavel_Jindra

Prim. Pavel Jindra: Biosimilars are an accessible and effective treatment modality in hematooncology

“Based on our experience so far, biosimilars represent an effective and safe alternative to…
24. 3. 2022 Source: Oncological Treatment
genetické testování

You can confirm or exclude ATTRv amyloidosis through genetic testing

16. 3. 2022 Source: Rare Diseases
maketa gynekologie

Combined Hormonal Contraception in the Treatment of Dysmenorrhea

Dysmenorrhea troubles many women of reproductive age and can deteriorate their quality of life,…
15. 3. 2022 Source: Oral Contraception
1 83 84 85 86 87 168
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#